Abstract:AIM: To develop a mathematical model for the early detection of hepatocellular carcinoma (HCC) with a panel of serum proteins in combination with α-fetoprotein (AFP).METHODS: Serum levels of interleukin (IL)-8, soluble intercellular adhesion molecule-1 (sICAM-1), soluble tumor necrosis factor receptor II (sTNF-RII), proteasome, and β-catenin were measured in 479 subjects categorized into four groups: (1) HCC concurrent with hepatitis C virus (HCV) infection (n = 192); (2) HCV related liver cirrhosis (LC) (n = 96); (3) Chronic hepatitis C (CHC) (n = 96); and (4) Healthy controls (n = 95). The R package and different modules for binary and multi-class classifiers based on generalized linear models were used to model the data. Predictive power was used to evaluate the performance of the model. Receiver operating characteristic curve analysis over pairs of groups was used to identify the best cutoffs differentiating the different groups.RESULTS: We revealed mathematical models, based on a binary classifier, made up of a unique panel of serum proteins that improved the individual performance of AFP in discriminating HCC patients from patients with chronic liver disease either with or without cirrhosis. We discriminated the HCC group from the cirrhotic liver group using a mathematical model (-11.3 + 7.38 × Prot + 0.00108 × sICAM + 0.2574 × β-catenin + 0.01597 × AFP) with a cutoff of 0.6552, which achieved 98.8% specificity and 89.1% sensitivity. For the discrimination of the HCC group from the CHC group, we used a mathematical model [-10.40 + 1.416 × proteasome + 0.002024 × IL + 0.004096 × sICAM-1 + (4.251 × 10(-4)) × sTNF + 0.02567 × β-catenin + 0.02442 × AFP] with a cutoff 0.744 and achieved 96.8% specificity and 89.7% sensitivity. Additionally, we derived an algorithm, based on a binary classifier, for resolving the multi-class classification problem by using three successive mathematical model predictions of liver disease status.CONCLUSION: Our proposed mathematical model may be a useful method for the early detection of different statuses of liver disease co-occurring with HCV infection.

USING ARTIFICIAL INTELLIGENCE METHODS FOR DETECTION OF HCV-CAUSED DISEASES

Artificial intelligence for hepatitis evaluation

Artificial Intelligence-Based Ensemble Learning Model for Prediction of Hepatitis C Disease

Artificial intelligence-based prediction of molecular and genetic markers for hepatitis C-related hepatocellular carcinoma

Hepatitis C Virus Network Based Classification of Hepatocellular Cirrhosis and Carcinoma

A machine learning-based treatment prediction model using whole genome variants of hepatitis C virus

Artificial intelligence in hepatocellular carcinoma diagnosis: a comprehensive review of current literature

An Approach Combining Feature Selection with Machine Learning Techniques for Prediction Reliability and Accuracy in Hepatitis Diagnosis

COVID-19 Detection Based on Blood Test Parameters using Various Artificial Intelligence Methods

A potential new way to facilitate HCV elimination: The prediction of viremia in anti-HCV seropositive patients using machine learning algorithms

Explainable Ensemble-Based Machine Learning Models for Detecting the Presence of Cirrhosis in Hepatitis C Patients

Artificial intelligence in precision medicine in hepatology

The best anti-HCV S/Co values for reflecting HCV infection in a university hospital in the eastern part of Turkey

Hybrid model for precise hepatitis-C classification using improved random forest and SVM method

Artificial intelligence techniques in liver cancer

Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model

The usefulness of anti-HCV signal to cut-off ratio in predicting hepatitis C viremia and the effect of genotype differences on signal to cut-off ratio

Data Centric Molecular Analysis and Evaluation of Hepatocellular Carcinoma Therapeutics Using Machine Intelligence-Based Tools

Opportunities and challenges for the application of artificial intelligence paradigms into the management of endemic viral infections: The example of Chronic Hepatitis C Virus

Revisiting artificial intelligence diagnosis of hepatocellular carcinoma with DIKWH framework

COVID-19 diagnosis from routine blood tests using artificial intelligence techniques